Johnson & Johnson’s Covid-19 Vaccine Trials Paused!

Across the globe, many countries and companies are working around the clock to develop the Covid-19 vaccine. However, the progress is not going as anticipated. Earlier Oxford university’s vaccine trials received breaks as a volunteer reported health complications. But after a few days, the university resumed its trails.

Yet another incident was reported and this time it is American multinational corporation Johnson & Johnson. The vaccine being developed by this company has been paused because one of its participants had become sick.

J&J has officially released a statement regarding its clinical trials and the company is not just conducting trials in the USA but also in Brazil, Argentina, Chile, Mexico, Columbia, Peru and South Africa. J&J has informed the labs owned by them to pause the trails until further notice.

This is the phase 3 of the J&J vaccine trails and it has planned to gather 60,000 participants across 200 cities in the world.

Coming to India’s total cases, it is at 71,75,881 with 55,342 new positive cases being reported in the last 24 hours. The active cases count has gone past the eight lakh mark and stands at 8,38,729 while 62,27,296 people have recovered.

706 people have died in the last 24 hours and the total death count is 1,09,856.